MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair
(NASDAQ:MBX), CARMEL, Ind., Jan. 22, 2026 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the appointment of Laurie Stelzer as an independent director on the Company's Board of Directors […]